LOS ANGELES, California, Oct. 20 [Category: BizHospital] -- Cedars-Sinai, a nonprofit academic healthcare organization, posted the following news:

* * *

Drug Combo Cuts Risk of Death in Advanced Prostate Cancer by 40%

*

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in clinical trials to cut the risk of death by more than 40%.

Stephen Freedland, MD